Form 4: Revolution Medicines Director Barbara Weber Reports Stock Sale
SEC Form 4 Filing
Director Barbara Weber of Revolution Medicines, Inc. reports selling 1,808 shares of common stock on August 21, 2024.
Summary
- On August 21, 2024, Barbara Weber, a director of Revolution Medicines, Inc., sold 1,808 shares of common stock.
- The sale price was $44.83 per share.
- Following the transaction, Weber directly owns 18,265 shares of Revolution Medicines, Inc., which includes 4,248 restricted stock units.
Sentiment
Score: 5
Explanation: This is a neutral disclosure of a stock sale by a company director. It doesn't inherently indicate positive or negative sentiment about the company's prospects.
Industry Context
This Form 4 filing is a routine disclosure required by the SEC when a company insider, such as a director, buys or sells shares of their company's stock. It provides transparency to the market regarding insider transactions.
Stakeholder Impact
- The sale of shares by a director could be perceived neutrally or slightly negatively by shareholders, depending on the context and the size of the transaction.
Key Dates
| Date | Description |
|---|---|
| 08/21/2024 | Date of stock sale transaction |
| 08/23/2024 | Date of Form 4 filing |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.